Thank you, Madam Chair.
Thank you, Mr. Jordan, for your testimony today.
I'd like to go back to a couple of comments you made in your opening statements related to board governance, because I would like to better understand. When we talk about advocacy, government relations, and lobbying, then you look at corporate boards.... From Rotman, you certainly have exposure to the ICD program--